跳至主要内容
临床试验/IRCT20130306012728N8
IRCT20130306012728N8招募中3 期

Prospective post-exposure hydroxycloroquine prophylaxis for Covid 19 (PROSCLOROCOV 19)

Tabriz University of Medical Sciences0 个研究点目标入组 500 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All persons 18 years of age and older with a desire to participate in the study (resident of Tabriz), including medical staff or patient companions who have been in contact with an approved person with COVID19 over the past 4 days, and Corona test results using a nasopharyngeal swap sample (RT-PCR) and serum testing of Human SARS-Cov-2 IgG / IgM negative.

排除标准

  • Positive Corona test result
  • Allergy to Hydroxychloroquine
  • Retinal disease
  • History of epilepsy
  • Known deficiency of glucose-6 phosphate dehydrogenase
  • Chronic kidney disease known, stage 4 or 5 or under dialysis
  • Chronic liver failure
  • Weight <40 kg
  • Known porphyria
  • Current use of hydroxychloroquine
  • History of cardiovascular disease or medication (such as amiodarone, digoxin, etc.)
  • Recognized cancers
  • Types of autoimmune diseases
  • Pregnancy or lactation
  • Existence of fever and any respiratory illness and other infectious diseases when entering the study

研究者

相似试验